Dr. Henry Lowe, a scientist who specializes in medicinal chemistry, has contributed immensely to the fields of science and technology, energy, the environment, wellness and health sciences nationally, regionally and internationally. Dr. Lowe is not only recognized as one of the region’s outstanding scientists but also public servant, author, educator and successful entrepreneur.
Dr. Lowe was born in St. Andrew, Jamaica and was educated at Calabar and Excelsior High Schools, University of the West Indies, (B.Sc. Hons.), University of Sydney, (M.Sc.), Manchester University, (Ph.D.), Bolton Institute of Technology England, (Dip. Technical Education), Harvard University and M.I.T, U.S.A., (Post-Doctoral Studies).
Dr. Lowe has discovered several bioactive molecules from Jamaican medicinal plants (particularly Jamaican Ball Moss) which are being developed for cancer therapy, diabetes and HIV/AIDS. He is also the holder of several patents based on the areas of his research in chronic diseases. Along with Drs. West and Lockhart, Dr. Lowe developed the first commercial product from Ganja for the treatment of Glaucoma.
Dr. Lowe holds many awards and accolades and is the only Jamaican who is a member of the prestigious American Association for Cancer Research (AACR).
Dr. Lowe established the first Nutraceutical industry in the Caricom region with significant financial potential for import substitution and the export market, which is a multibillion market. Dr. Lowe is the founder and Executive Chairman of the EHF Group of Companies, which includes a private, not for profit organization, Environmental Health Foundation (EHF), established in 1992, to enhance the quality of people’s lives in Jamaica.